Showing results (1-10 of 361) with videos related to
Sort By:
Pageof 37
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
BiomarkersJuan ForteaExpert Review of Neurotherapeutics|July 2, 2025
An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's diseaseJuan Fortea, Elena Ferrer-PicónJournal of Clinical Medicine|July 2, 2021
Epilepsy in Down Syndrome: A Highly Prevalent ComorbidityMiren Altuna, Sandra Giménez, Juan ForteaAmerican Journal on Intellectual and Developmental Disabilities|October 28, 2015
Patterns of Performance on the Modified Cued Recall Test in Spanish Adults With Down Syndrome With and Without DementiaBessy Benejam, Juan Fortea, Rafael Molina-López, et al.Developmental Neurobiology|July 7, 2019
Down syndrome, Alzheimer disease, and cerebral amyloid angiopathy: The complex triangle of brain amyloidosisMaría Carmona-Iragui, Laura Videla, Alberto Lleó, et al.International Journal of Molecular Sciences|April 23, 2022
Mechanisms Involved in Epileptogenesis in Alzheimer's Disease and Their Therapeutic ImplicationsMiren Altuna, Gonzalo Olmedo-Saura, María Carmona-Iragui, et al.Current Topics in Behavioral Neurosciences|November 7, 2024
What Can We Learn About Alzheimer's Disease from People with Down Syndrome?Lucia Maure-Blesa, Iñigo Rodríguez-Baz, Maria Carmona-Iragui, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|June 26, 2024
Occurrence of mosaic Down syndrome and prevalence of co-occurring conditions in Medicaid enrolled adults, 2016-2019Eric Rubenstein, Salina Tewolde, Brian G Skotko, et al.Journal of Clinical Medicine|July 24, 2021
Sleep Disorders in Adults with Down SyndromeSandra Giménez, Miren Altuna, Esther Blessing, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 18, 2017
Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndromeAlain D Dekker, Juan Fortea, Rafael Blesa, et al.Pageof 37